Your trusted source for investing success

Tag: financial results

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access

Cytokinetics Reports Fourth Quarter 2017 Financial Results

Cytokinetics (Nasdaq:CYTK) reported financial results for the fourth quarter of 2017. Net loss for the fourth quarter was $40.5 million, or $0.75 per basic share and diluted share, respectively, compared to net income for the same period in 2016 of $7.2 million, or $0.18 and $0.16 per basic and diluted

Allscripts announces fourth quarter and 2017 full-year results

Allscripts Healthcare Solutions (NASDAQ:MDRX) announced its financial results for the three months and year ended December 31, 2017.

As quoted in the press release:
Fourth quarter 2017 GAAP revenue was $517 million, an increase of 22 percent year-over-year. Non-GAAP revenue totaled $547 million, improving 27 percent year-over-year. For the year ended December

Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results

Genocea Biosciences (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2017 and recent corporate developments.

As quoted in the press release:
“We’ve had a productive start to 2018 and are encouraged by both the progress with our lead neoantigen

Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results

Ohr Pharmaceutical (Nasdaq:OHRP), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results and operating highlights for its fiscal first quarter ended December 31, 2017.

As quoted in the press release:
“We recently announced top-line results from the MAKO study evaluating the efficacy and safety of topically administered squalamine in

Prothena Reports Fourth Quarter and Full Year 2017 Financial Results

Prothena (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today reported financial results for the fourth quarter and full year 2017. In addition, the Company provided 2018 financial guidance and an update on its R&D programs.

As

Fintech Stocks in Canada

Fintech Stocks in Canada

While the current state of the Canadian fintech market pales in comparison to the rest of the world, its uses and adoptions are expected to increase in the country. Here are nine fintech stocks in Canada.

Oncobiologics Reports First Quarter Fiscal Year 2018 Results

Oncobiologics (NASDAQ:ONS) today reported financial results and business highlights for its first fiscal quarter ended December 31, 2017. Oncobiologics had a net loss attributable to common stockholders of $17.7 million for the three months ended December 31, 2017 and total cash of $ 13.8 million at December 31, 2017.  On

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2017. In addition, Agios highlighted select 2018 corporate milestones and data presentations for its clinical development

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Weekly NASDAQ Tech Stocks: Index on Pace for Best Week in 6 Years

URL: https://investingnews.com/daily/tech-investing/data-investing/weekly-nasdaq-tech-stocks/